8 results on '"Diamantopoulos, Aristidis"'
Search Results
2. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study
- Author
-
Deutschbein, Timo, Reimondo, Giuseppe, Di Dalmazi, Guido, Bancos, Irina, Patrova, Jekaterina, Vassiliadi, Dimitra Argyro, Nekić, Anja Barač, Debono, Miguel, Lardo, Pina, Ceccato, Filippo, Petramala, Luigi, Prete, Alessandro, Chiodini, Iacopo, Ivović, Miomira, Pazaitou-Panayiotou, Kalliopi, Alexandraki, Krystallenia I, Hanzu, Felicia Alexandra, Loli, Paola, Yener, Serkan, Langton, Katharina, Spyroglou, Ariadni, Kocjan, Tomaz, Zacharieva, Sabina, Valdés, Nuria, Ambroziak, Urszula, Suzuki, Mari, Detomas, Mario, Puglisi, Soraya, Tucci, Lorenzo, Delivanis, Danae Anastasia, Margaritopoulos, Dimitris, Dusek, Tina, Maggio, Roberta, Scaroni, Carla, Concistrè, Antonio, Ronchi, Cristina Lucia, Altieri, Barbara, Mosconi, Cristina, Diamantopoulos, Aristidis, Iñiguez-Ariza, Nicole Marie, Vicennati, Valentina, Pia, Anna, Kroiss, Matthias, Kaltsas, Gregory, Chrisoulidou, Alexandra, Marina, Ljiljana V, Morelli, Valentina, Arlt, Wiebke, Letizia, Claudio, Boscaro, Marco, Stigliano, Antonio, Kastelan, Darko, Tsagarakis, Stylianos, Athimulam, Shobana, Pagotto, Uberto, Maeder, Uwe, Falhammar, Henrik, Newell-Price, John, Terzolo, Massimo, and Fassnacht, Martin
- Published
- 2022
- Full Text
- View/download PDF
3. A Prospective Study on Neural Biomarkers in Patients with Long-COVID Symptoms.
- Author
-
Vrettou, Charikleia S., Vassiliou, Alice G., Keskinidou, Chrysi, Mourelatos, Panagiotis, Asimakos, Andreas, Spetsioti, Stavroula, Diamantopoulos, Aristidis, Jahaj, Edison, Antonoglou, Archontoula, Katsaounou, Paraskevi, Vassiliadi, Dimitra A., Kotanidou, Anastasia, and Dimopoulou, Ioanna
- Subjects
POST-acute COVID-19 syndrome ,GLIAL fibrillary acidic protein ,TAU proteins ,LONGITUDINAL method ,SYMPTOMS ,POST-traumatic stress disorder - Abstract
Background: this prospective observational study aims to assess serum levels of glial fibrillary acidic protein (GFAP), s100b, and total Tau in long-COVID patients, exploring correlations with symptoms, cognitive decline, mental health, and quality of life. Methods: Long-COVID patients visiting our outpatient clinic (February 2021–December 2022) were screened alongside age- and sex-matched controls. GFAP, s100b, and total Tau in serum were measured with ELISA. Cognitive function, depression, anxiety, post-traumatic stress disorder, and quality of life were evaluated using MoCA, HADS (depression and anxiety), IES-R, and SF-36, respectively. Results: Sixty-five long-COVID patients and 20 controls were included. GFAP levels were significantly higher in long-COVID patients (p = 0.031), though not correlating with the presence of long-COVID symptoms. S100b and total Tau showed no significant differences between patients and controls. Nervous system-related symptoms were reported in 47% of patients. High rates of cognitive decline (65.9%), depression (32.2%), anxiety (47.5%), and post-traumatic stress disorder (44.1%) were observed. Over 80% of the study population scored below normative cutoffs for SF-36, indicating a significant impact on quality of life. Conclusions: in this long-COVID cohort with substantial psychological and cognitive symptoms, GFAP levels were elevated compared to controls, though not correlating with the presence of long-COVID symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Persistent Endothelial Lung Damage and Impaired Diffusion Capacity in Long COVID.
- Author
-
Asimakos, Andreas T., Vassiliou, Alice G., Keskinidou, Chrysi, Spetsioti, Stavroula, Antonoglou, Archontoula, Vrettou, Charikleia S., Mourelatos, Panagiotis, Diamantopoulos, Aristidis, Pratikaki, Maria, Athanasiou, Nikolaos, Jahaj, Edison, Gallos, Parisis, Kotanidou, Anastasia, Dimopoulou, Ioanna, Orfanos, Stylianos E., and Katsaounou, Paraskevi
- Subjects
POST-acute COVID-19 syndrome ,LUNGS ,LUNG volume measurements ,PROGNOSTIC tests ,FUNCTIONAL status - Abstract
Since the beginning of the pandemic, both COVID-19-associated coagulopathy biomarkers and a plethora of endothelial biomarkers have been proposed and tested as prognostic tools of severity and mortality prediction. As the pandemic is gradually being controlled, attention is now focusing on the long-term sequelae of COVID-19. In the present study, we investigated the role of endothelial activation/dysfunction in long COVID syndrome. This observational study included 68 consecutive long COVID patients and a healthy age and sex-matched control group. In both groups, we measured 13 endothelial biomarkers. Moreover, in the long COVID patients, we evaluated fatigue and dyspnea severity, lung diffusion capacity (DLCO), and the 6-min walk (6MWT) test as measures of functional capacity. Our results showed that markers of endothelial activation/dysfunction were higher in long COVID patients, and that soluble intracellular adhesion molecule 1 (sICAM-1) and soluble vascular adhesion molecule 1 (sVCAM-1) negatively correlated with lung diffusion and functional capacity (sICAM-1 vs. DLCO, r = −0.306, p = 0.018; vs. 6MWT, r = −0.263, p = 0.044; and sVCAM-1 vs. DLCO, r= −0.346, p = 0.008; vs. 6MWT, r = −0.504, p < 0.0001). In conclusion, evaluating endothelial biomarkers alongside clinical tests might yield more specific insights into the pathophysiological mechanisms of long COVID manifestations. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Endocrine Aspects of ICU-Hospitalized COVID-19 Patients.
- Author
-
Diamantopoulos, Aristidis, Dimopoulou, Ioanna, Mourelatos, Panagiotis, Vassiliou, Alice G, Vassiliadi, Dimitra-Argyro, Kotanidou, Anastasia, and Ilias, Ioannis
- Subjects
- *
INTENSIVE care units , *COVID-19 , *SOMATOMEDIN C , *MACHINE learning - Abstract
The unprecedented scale of the current SARS-CoV-2/COVID-19 pandemic has led to an extensive—yet fragmented—assessment of its endocrine repercussions; in many reports, the endocrine aspects of COVID-19 are lumped together in intensive care unit (ICU) patients and non-ICU patients. In this brief review, we aimed to present endocrine alterations in ICU-hospitalized patients with COVID-19. There are tangible endocrine disturbances that may provide fertile ground for COVID-19, such as preexisting diabetes. Other endocrine disturbances accompany the disease and more particularly its severe forms. Up to the time of writing, no isolated robust endocrine/hormonal biomarkers for the prognosis of COVID-19 have been presented. Among those which may be easily available are admission glycemia, thyroid hormones, and maybe (OH)25-vitamin D3. Their overlap among patients with severe and less severe forms of COVID-19 may be considerable, so their levels may be indicative only. We have shown that insulin-like growth factor 1 may have prognostic value, but this is not a routine measurement. Possibly, as our current knowledge is expanding, the inclusion of selected routine endocrine/hormonal measurements into artificial intelligence/machine learning models may provide further information. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Testosterone, free, bioavailable and total, in patients with COVID-19.
- Author
-
ILIAS, Ioannis, PRATIKAKI, Maria, DIAMANTOPOULOS, Aristidis, JAHAJ, Edison, MOURELATOS, Panagiotis, ATHANASIOU, Nikolaos, TSIPILIS, Stamatios, ZACHARIS, Alexandros, VASSILIOU, Alice G., VASSILIADI, Dimitra A., TSAGARAKIS, Stylianos, KOTANIDOU, Anastasia, and DIMOPOULOU, Ioanna
- Published
- 2022
- Full Text
- View/download PDF
7. Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study.
- Author
-
Prete, Alessandro, Subramanian, Anuradhaa, Bancos, Irina, Chortis, Vasileios, Tsagarakis, Stylianos, Lang, Katharina, Macech, Magdalena, Delivanis, Danae A., Pupovac, Ivana D., Reimondo, Giuseppe, Marina, Ljiljana V., Deutschbein, Timo, Balomenaki, Maria, O'Reilly, Michael W., Gilligan, Lorna C., Jenkinson, Carl, Bednarczuk, Tomasz, Zhang, Catherine D., Dusek, Tina, and Diamantopoulos, Aristidis
- Subjects
ADRENAL tumors ,HEART metabolism disorders ,BENIGN tumors ,MEDICAL education ,TANDEM mass spectrometry ,MEDICAL sciences ,CUSHING'S syndrome diagnosis ,HYPERTENSION ,RESEARCH ,CUSHING'S syndrome ,CROSS-sectional method ,RESEARCH methodology ,CARDIOVASCULAR diseases ,EVALUATION research ,TYPE 2 diabetes ,COMPARATIVE studies ,RESEARCH funding ,HYDROCORTISONE ,DISEASE complications - Abstract
Background: Benign adrenal tumors are commonly discovered on cross-sectional imaging. Mild autonomous cortisol secretion (MACS) is regularly diagnosed, but its effect on cardiometabolic disease in affected persons is ill defined.Objective: To determine cardiometabolic disease burden and steroid excretion in persons with benign adrenal tumors with and without MACS.Design: Cross-sectional study.Setting: 14 endocrine secondary and tertiary care centers (recruitment from 2011 to 2016).Participants: 1305 prospectively recruited persons with benign adrenal tumors.Measurements: Cortisol excess was defined by clinical assessment and the 1-mg overnight dexamethasone-suppression test (serum cortisol: <50 nmol/L, nonfunctioning adrenal tumor [NFAT]; 50 to 138 nmol/L, possible MACS [MACS-1]; >138 nmol/L and absence of typical clinical Cushing syndrome [CS] features, definitive MACS [MACS-2]). Net steroid production was assessed by multisteroid profiling of 24-hour urine by tandem mass spectrometry.Results: Of the 1305 participants, 49.7% had NFAT (n = 649; 64.1% women), 34.6% had MACS-1 (n = 451; 67.2% women), 10.7% had MACS-2 (n = 140; 73.6% women), and 5.0% had CS (n = 65; 86.2% women). Prevalence and severity of hypertension were higher in MACS-2 and CS than NFAT (adjusted prevalence ratios [aPRs] for hypertension: MACS-2, 1.15 [95% CI, 1.04 to 1.27], and CS, 1.37 [CI, 1.16 to 1.62]; aPRs for use of ≥3 antihypertensives: MACS-2, 1.31 [CI, 1.02 to 1.68], and CS, 2.22 [CI, 1.62 to 3.05]). Type 2 diabetes was more prevalent in CS than NFAT (aPR, 1.62 [CI, 1.08 to 2.42]) and more likely to require insulin therapy for MACS-2 (aPR, 1.89 [CI, 1.01 to 3.52]) and CS (aPR, 3.06 [CI, 1.60 to 5.85]). Urinary multisteroid profiling revealed an increase in glucocorticoid excretion from NFAT over MACS-1 and MACS-2 to CS, whereas androgen excretion decreased.Limitations: Cross-sectional design; possible selection bias.Conclusion: A cardiometabolic risk condition, MACS predominantly affects women and warrants regular assessment for hypertension and type 2 diabetes.Primary Funding Source: Diabetes UK, the European Commission, U.K. Medical Research Council, the U.K. Academy of Medical Sciences, the Wellcome Trust, the U.K. National Institute for Health Research, the U.S. National Institutes of Health, the Claire Khan Trust Fund at University Hospitals Birmingham Charities, and the Mayo Clinic Foundation for Medical Education and Research. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
8. Increased Glucocorticoid Receptor Alpha Expression and Signaling in Critically Ill Coronavirus Disease 2019 Patients.
- Author
-
Vassiliou, Alice G., Athanasiou, Nikolaos, Keskinidou, Chrysi, Jahaj, Edison, Tsipilis, Stamatios, Zacharis, Alexandros, Botoula, Efthimia, Diamantopoulos, Aristidis, Ilias, Ioannis, Vassiliadi, Dimitra A., Tsagarakis, Stylianos, Kotanidou, Anastasia, and Dimopoulou, Ioanna
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.